Takefumi Suzuki

7.6k citations
234 papers · 4.6k indexed · h-index 37
Topics
Schizophrenia research and treatment (108 papers)Treatment of Major Depression (52 papers)Bipolar Disorder and Treatment (47 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyPLoS ONE
Partner nations
JapanCanadaUnited States

In The Last Decade

Takefumi Suzuki

224 papers receiving 4.5k citations

Peers

Takefumi Suzuki
Comparison fields: 5 of 151
  • Psychiatry and Mental health 2.6k
  • Pharmacology 797
  • Clinical Psychology 766
  • Molecular Biology 551
  • Experimental and Cognitive Psychology 430
Replace Koichiro Watanabe with:
Koichiro Watanabe Japan
Oliver Freudenreich United States
Jimmi Nielsen Denmark
Mariëlle Eerdekens United States
William V. Bobo United States
Ross A. Baker United States
Keith L. Davis United States
Francesco Monaco Italy
Rafael Tabarés‐Seisdedos Spain
Ramy Mahmoud United States
Takefumi Suzuki relative to Koichiro Watanabe Japan Koichiro Watanabe's profile →
Citations per field
00.5×1.5×2.0×
Koichiro Watanabe · 1×
Citations per year

Countries citing papers authored by Takefumi Suzuki

Since Specialization
Citations

This map shows the geographic impact of Takefumi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Suzuki more than expected).

Fields of papers citing papers by Takefumi Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Suzuki. The network helps show where Takefumi Suzuki may publish in the future.

Co-authorship network of co-authors of Takefumi Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Takefumi Suzuki. A scholar is included among the top collaborators of Takefumi Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takefumi Suzuki. Takefumi Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 5
4 5
5 25
6 5
7 6
8 1
9 18
10 52
11
Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: a pilot PET study.
1
12 21
13 80
14 21
15 8
16 34
17 48
18 4
19 57
20
[Experiences in general anesthesia of patients with scoliosis presupposed to have difficulties in airway maintenance].
5

About Takefumi Suzuki

Takefumi Suzuki is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry, having authored 234 papers that have together received 4.6k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (108 papers), Treatment of Major Depression (52 papers) and Bipolar Disorder and Treatment (47 papers). The work is most often cited by research in Psychiatry and Mental health (2.6k citations), Biological Psychiatry (310 citations) and Pharmacology (797 citations). Takefumi Suzuki has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Hiroyuki Uchida, Masaru Mimura, Koichiro Watanabe, Hiroyoshi Takeuchi, David C. Mamo, Haruo Kashima, Ariel Graff‐Guerrero, Gary Remington, Shinichiro Nakajima and Tarek K. Rajji. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026